Dr. Henry Smilowitz
Undergraduate Research Opportunity Description
|Project Description||Our lab collaborates with a small biotech company to study heavy atom nanoparticles as both blood pool contrast agents and as enhancers of radiation therapy for tumor therapy. Our lab also studies the combination of radiation therapy and immunotherapy for tumor therapy with and emphasis on brain tumor therapy. We are currently studying a novel heavy atom nanoparticle for its translation potential to patients for applications related to the above utilities. Any student interested in these types of studies should get in touch with Dr. Smilowitz to discuss specific, timely projects.|
|Project Direction||The projects in our lab relate to enhancing the efficacy of radiation therapy of brain tumors and other types of tumors as well as the development of new x-ray contrast agents that may be safer for patients with preexisting kidney disease. We are also interested in using our advanced intracerebral melanoma model to study therapy-induced tumor dormancy and develop new combination immunotherapies to be combined with radiation therapy.|
|Mentorship and Supervision||Student will work closely with Dr. Smilowitz and lab personnel|
|Student Qualifications||Rising senior with plans to go to medical school or graduate school in biomedical research. Prior research experience is desirable.|
|Summer Schedule Options||Research Dates: 9-10 full-time weeks to be scheduled between May 8 and August 25, 2017
Schedule: M-F, 9am-5pm, plus possibilities for work on the Storrs campus from time to time
|Project Continuation||Fall 2017, Spring 2018|
|Academic Year Time Commitment||3-9 hours/week|
|Possible Thesis Project||Yes|
Submit an online application for this research opportunity using the form below. The application deadline is Friday, February 24, 2017.
This application requires a cover letter, a resume or CV, an unofficial transcript, a brief statement of research interests, and a brief statement of career interests. You must also arrange to have at least one letter of recommendation sent to Dr. Smilowitz by February 24th (see details below).